FAQs

Frequently Asked Questions

Clinical research is advanced clinical care. It involves scientific investigation to understand, prevent, diagnose, or treat medical conditions. It typically includes clinical trials and other research studies involving human participants.

Clinical trials are research studies designed to evaluate new medical interventions such as drugs, devices, or treatments in humans. They aim to assess safety, efficacy, and potential side effects.

Clinical research is conducted by a variety of entities, including academic institutions, pharmaceutical companies, medical centers, and government agencies. Researchers and investigators lead these studies.

Informed consent is a process where participants are provided with detailed information about the study, including its purpose, risks, benefits, and procedures. Participants must voluntarily agree to participate after understanding the information.

Clinical research follows strict ethical guidelines and regulatory standards to protect the rights, safety, and well-being of participants. Institutional Review Boards (IRBs) or Ethics Committees review and approve research protocols.

Individuals can participate in clinical trials by contacting INNOVACORE. Contact Us.

 

Participants undergo specific interventions or procedures outlined in the study protocol. This may include taking a new medication, receiving a treatment, or providing biological samples. Regular follow-up visits and monitoring are common.

 

Clinical trials prioritize participant safety. Protocols are carefully designed, and ongoing monitoring is conducted to identify and address any potential risks. The decision to participate should be made after careful consideration.

Participants have the right to withdraw from a clinical trial at any time for any reason. Researchers will explain the potential consequences of withdrawal during the informed consent process.

Clinical trials typically progress through phases (I-IV). Phase I assesses safety, Phase II evaluates efficacy, Phase III confirms results, and Phase IV monitors long-term safety and effectiveness after regulatory approval.

 

Randomization is a process used to assign participants randomly to different treatment groups. This helps ensure unbiased results and allows researchers to compare the effects of different interventions.

Some clinical trials involve placebos (inactive substances) for comparison. Participants are informed if placebos are used, and the decision to use placebos is carefully considered during the trial design.

Clinical trials may include individuals with specific health conditions, as well as healthy volunteers. Some trials focus on prevention or early detection rather than treatment.

Benefits may include access to new treatments, close medical monitoring, and contributing to scientific knowledge. Risks can include side effects, discomfort, and uncertainty about the treatment’s effectiveness.

Most clinical trials cover the costs of interventions and medical visits, including providing a small stipend to the participant. Participants should clarify financial aspects during the informed consent process.

Privacy is a priority in clinical research. Personal information is kept confidential, and data is anonymized whenever possible. Regulatory standards and ethical guidelines govern data protection.

Researchers often share study results through scientific publications, conferences, or online platforms. Participants may request study results from the research team.

Some studies may allow participation in multiple trials, but it depends on the specific protocols and eligibility criteria. Researchers will provide guidance on this matter.

After a clinical trial concludes, researchers analyze the data, publish findings, and may seek regulatory approval for the intervention. Participants are typically informed about the results and any plans for further development.

Individuals interested in learning more about clinical research can obtain this information from the following sources:

Skip to content